We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Methylation Enzyme Modifies Gene Behavior

By Biotechdaily staff writers
Posted on 24 May 2002
An enzyme has been found that attaches methyl groups to histone proteins and represses the activity of certain genes. The research was reported in the April 15, 2002, issue of Genes and Development.

Histone proteins are packaged together with DNA in the chromosomes. If methylation of these proteins is blocked, genes that normally are repressed may become activated. Such activated genes may transform normal cells into cancerous ones.

"In this study we showed that when this enzyme is active at a particular gene, it places a molecular marker on the gene, says Dr. Frank J. Rauscher III, a professor at The Wistar Institute (Philadelphia, PA, USA). "This molecular marker is crucial in silencing sets of genes.” Loss of this molecular marker from a particular set of genes in a normally nonaggressive breast cancer can cause it to become very aggressive and metastatic.

"Now that we have found a new enzyme that is required for the silencing of certain genes,” states Dr. Rauscher, "we believe it will be possible to create specific drugs that can either repress or activate gene expression through the targeting of this enzyme. This could lead to therapies for cancer and, specifically, for controlling the metastatic spread of cancer.”




Related Links:
The Wistar Institute

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Aspiration System
VACUSAFE
New
Rapid Sepsis Test
SeptiCyte RAPID
New
POC Immunoassay Analyzer
Procise DX

Latest BioResearch News

Microenvironment Biomarkers Could Enable Early Lung Cancer Detection
24 May 2002  |   BioResearch

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
24 May 2002  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
24 May 2002  |   BioResearch